Abstract: The discovery of novel drugs against animalp arasites is in high demandd ue to drug-resistance problems encountered around the world. Herein, the synthesis and characterization of 27 organic ando rganometallic derivatives of the recently launched nematocidal drug monepantel (Zolvix )a re described. The compounds were isolated as racemates and were characterized by 1 H,
Introduction
Multicellular parasites,i ncludingroundworms( nematodes), flatworms( trematodesa nd cestodes), and arthropods( e.g., fleas, flies, and ticks), cause morbidity and mortality in animals worldwide, [1] which result in as ubstantial loss to global food production annually. [1b, g] The control of parasitesr elies largely on the use of antiparasitic drugs.
[2] However,d rug resistance is now quite widespread. [1a, 3] Therefore,t he development of new drugso rc hemicalm odificationo fe xisting drugs is crucial to ensure sustainable chemical control of parasites in the future.
In this context,t he discovery of the structurally new aminoacetonitrile class of synthetica ntiparasitic compounds (AADs, see Figure 1 ) by Novartis Animal Health was am ajor breakthrough in 2008. [4] An extensive structure-activity relationship (SAR) study resulted in the development of monepantel (AAD 1566,F igure 1), which was released undert he trade name Zolvix in 2009 fort he treatment of nematode infections in sheep. [5] Monepantel targetsl igand-gated ion channels in the nematode-specific DEG-3 family. [4] These channels are related to nicotinic acetylcholine receptors, but they are gated by betaine and choline rather than acetylcholine. [6] Monepantel acts on MPTL-1 receptors in Haemonchus contortus and the homologuesA CR-20 and ACR-23i nt he free-living nematode Caenorhabditis elegans.T he drug acts as ap ositive allosteric modula- tor,h yperactivating these channels. [6c, 7] An in vitro selection procedure by Rufener et al. revealed that monepantel resistance in H. contortus can develop relatively rapidlyb yasingle loss-of-function mutation. Indeed, monepantel-resistant worms in livestock were reported within afew years. [3d, e, 8] It is of increasing importance to search for structurally or functionally unique classes of compounds to control parasites. [3a] To date, this quest has been focused mainly on organic compounds, but metal-based compounds have had an impressive success in other fields of medicinal chemistry.
[9] Specifically, recent efforts have identified anticancer, [10] antimalarial, [11] antitrypanosomal, [12] antibacterial, [13] and antischistosomal [14] compounds. Organometallic complexes (i.e., compounds with at least one direct metalÀcarbon bond) are ac lass of metal compounds that have shown promise as anti-infectives. [13, 15] Ferroquine, the ferrocenyl analogue of the antimalarial drug chloroquine, is the most prominente xample of an organometallic drug candidateu sed against parasites. The introductiono f af errocenyl moiety alters the mode of action of the parent drug and renders it active against chloroquine-resistant Plasmodium falciparum strains. [11a] Similarly,a na ltered mode of action was evident in the ferrocenyl derivative of the anticancer drug tamoxifen, namedf errocifen. Whereas tamoxifen is only active against estrogen-positive breast cancers, ferrocifen is active against both estrogen-negative and estrogen-positive cancers.
[16] To the best of our knowledge,o rganometallic complexes have rarely been tested for nematocidala ctivity. [17] With the aim of developing new classes of nematocidal drugs, we recently initiated ap rogramt od esign and test organometallic analogues of the organic anthelminticm onepantel. The aryloxy unit of the original molecule was substituted with sandwich (ferrocene, ruthenocene) and half-sandwich (cymantrene) organometallic moieties in order to introduce metal-specific modes of action, as well as with various organic moieties. The functional groups at the benzamide unit of the organometallic and organic analogue were further varied (SCF 3 ,O CF 3 ,C F 3 ,F ,C l, Br,I ,e tc.). The presence of different functional groups is expected to modulate the lipophilicity,b iodistribution, and pharmacokinetic properties, therebyi nfluencing the biological properties of the newly designed monepantel analogues.T hese modifications resultedi nalibrary of 27 organic/organometallic derivatives of monepantel for SAR studies. The initial biological screenings reported herein demonstrate that some of the compounds retain activity against monepantel targets,w hile gaining novel properties such as the production of reactive oxidative species( ROS). Additionally, we demonstrate for the first time that AADs,i ncluding our organic and organometallica nalogues, show activity against Dirofilaria immitis microfilariae.
Results and Discussion

Design of organometallic analogues
Monepantel consists of an aryloxy and ab enzamide unit connected by ac hiral C 2 spacer.Preliminary metabolism studies indicatedt hat the benzamideu nit plays ac rucial role in the in vivo activity of monepantel.
[18] Therefore, with the intention to keep the benzamide part in place, we designed our first organometallic monepantel analogues by replacing the aryloxy part of monepantel with af errocenyl unit (Scheme 1). The ferrocene/ferrocenium system has redoxp roperties favorable for production of ROS, whichc an improve toxicity,a ss hown for ferroquine and ferrocifen. [11b, 19] Subsequently,w ee mployed two different strategies to study the SAR of monepantel analogues. In Strategy I, as eries of organica nd organometallic derivatives were synthesized in which the functional group at the 4-position of the benzamide moiety was varied (Scheme 1). In Strategy II (Scheme 1), we designed organic and organometallic derivatives of 5a in order to evaluate the importance of the organometallic moiety.F or this purpose, the ferrocenyl subunit was swappedw ith two different organometallicm oieties, namely,r uthenocene and cymantrene. Replacing the Fe II core with ac omparatively inert Ru II centerm ay allow us to probe the relevance of Fe II /Fe III -mediated redox activity of the compound. By contrast to ferrocene and ruthenocene, cymantrene conjugates of organic drugs are rarely studied fort heir antiparasitic potency.
[20] The metal centeri nc ymantrene is isoelectronic to that of ferrocene and the two metallocenesa re nearly isosteric. However,t hey have different redox behavior,a nd the metal centers are in + 1a nd + 2o xidation states in cymantrene and ferrocene, respectively.T herefore, comparison of these metallocenyla nalogues should illuminate anym etalmediated modes of action of our compounds.
Synthesis and characterization
Organometallic analogues 5a-5h were prepared in at wo-step procedure as outlined in Scheme2.T he centralc ore, 2-amino-2-hydroxymethylproprionitrile (1), was synthesized by following the procedure described by Gauvry et al. [21] In asubsequent reaction, the amide bond between 1 and the commercially availablec ompounds 2a-2h bearing ac hlorocarbonyl moiety was formed. Initially,w ea ttempted to synthesize 3a by following the procedure of Gauvry et al. [21] However,i nstead of the desired compound, two different products,n amely 2-cyano-2-{4-[(trifluoromethyl)thio]benzamido}propyl acetate (3l)a nd 2-cyano-2-{4-[(trifluoromethyl)thio]benzamido}propyl 4-[(trifluoromethyl) thio]benzoate( 3m)w ere isolated in yields of 21 %a nd 3%,r espectively (Scheme 2). Therefore, we improved the protocol by changing the base from sodiumh ydroxide to triethylamine, which resulted in the formation of the desired 3a in 74 %y ield. By followingt he same procedure, compounds 3b-3h werei solated in moderate to good yields. Compound 3a was furthert reated with benzoyl chloride under basic conditions, and compound 3n waso btained in 86 %y ield. Finally, esterification of 3a-3h with ferrocenecarboxylic acid (4)y ielded the desired compounds 5a-5h as yellow or orange solids. Although it was shown that the efficacy of AADs against nematodes is enantioselective, we decided to perform the synthesis and biological evaluation with the organometallic racemates (5a-5h). Lower potencyi se xpected for racemic mixtures rather than enantiopure compounds, but this approach provided an initial estimation of potency.
Chem. Eur.J. 2016, 22,16602 -16612 www.chemeurj.org Monepantel is rapidlym etabolized in vivo to the sulfone derivative, with the correspondings ulfoxide as an intermediate. [18, 22] Because these are active metabolites, [22] we synthesized the sulfone and sulfoxide derivatives of 5a (5j and 5k, Scheme3). For this purpose, the SCF 3 functionality of 3a was selectively oxidized with different equivalents of meta-chloroperoxybenzoic acid( m-CPBA) at À78 8C. The resulting organic precursors 3j and 3k were isolated as colorless solids in moderate yields. Esterificationo f3j or 3k with 4 yielded the final ferrocenyl-based sulfoxide and sulfone derivatives, 2-cyano-2-Scheme1.Schematicrepresentation of the design of organometallic derivatives based on the lead structure of AAD 1566 (monepantel).
Scheme2.Reagents and conditions: i) NEt 3 ,dry CH 2 Cl 2 ,1 .5 h-24 h, r.t.,26% À74 %. ii)a)Ferrocenecarboxylic acid (4), oxalylchloride, dry CH 2 Cl 2 ,r .t.;b)NEt 3 , dry CH 2 Cl 2 ,o vernight (o.n.), r.t.,25%-9 4% after two steps. iii)4-(Trifluoromethylthio)benzoylc hloride, dry ethyl acetate, 1 m NaOH, 3h,r .t.,21% (3l)a nd 3% (3m). iv) Benzoyl chloride, NEt 3 ,d ry CH 2 Cl 2 ,2h, r.t. 86 %( 3n).
Chem. Eur.J. 2016, 22,1 6602-16612 www.chemeurj.org The ferrocenyl moiety of 5a was replaced with two different organometallic moietiest oa ssess their effect on the anthelmintic activity.I nc ontrastt ot he ferrocenyl derivative 5a,t he cymantrene derivative 9a and ruthenocene derivative 9b (Scheme 4) are not expected to produce ROS. Compounds 9a and 9b were synthesized by following the synthetic pathway outlined in Scheme 4. Initially, cymantrene carboxylic acid (8a) and ruthenocenyl carboxylic acid (8b)w ere synthesized according to published procedures.
[23] Whereas 8a wasl inked to 3a by ao ne-step Steglich esterification reaction, 8b required activation with oxalyl chloride and then reactionw ith 3a.
To assesst he importance of the chiral C 2 spacer between the aryloxy andb enzamide units, two additional organometallic derivatives were synthesized.C ompounds 7a and 7b contain benzamide and aryloxy units, respectively,w hich are connected to af errocenyl moiety via an amide or an ether functionality,r ather than the C 2 spacer (Scheme5). The organometallic precursors ferrocenylmethylamine (6a)a nd hydroxymethylferrocene (6b)w eres ynthesized following published procedures.
[24] Compound 7a was then readily prepared by amide bond formation of 6a with commercially available 4-(trifluoromethylthio)benzoyl chloride under alkaline conditions and N-ferrocenyl-4-(trifluoromethylthio)benzamide (7a)w as isolated as ab right yellow solid. 3-(Ferrocenyloxy)-4-(trifluoromethyl)benzonitrile (7b)w as isolateda fter an aromatic nucleophilic substitution reaction with the ferrocenyl alcohol (Scheme 5).
All new compounds were unambiguously characterized by 1 H, 13 C, and 19 FNMR spectroscopy,m ass spectrometry,a nd IR spectroscopy,a nd their puritiesw ere verified by elemental analysis( see Experimental Sectiona nd Supporting Information for further details). The 13 CNMR spectra of the compounds containing af luorine atom (3a, 3b, 3g, 3h, 3j, 3k, 3l, 3m, 3n, 5a, 5b, 5g, 5h, 5j, 5k, 7a, 7b, 9a,and 9b) 
X-ray crystallography
The structures of compounds 3a, 3b, 3f, 3g, 5a, 5c, 5d, 5h, and 5k were further corroborated by single-crystal X-ray diffraction studies. Example structures of 3f and 5d are shown in Figure 2 ( see Figure S1 -S3 in the Supporting Information for the other structures). The X-ray diffraction studies confirmed the formation of the amide bond between the 2-amino-2-hydroxymethylproprionitrile species 1 and the substituted compounds 2a-2h through the carbonyl group to form the monepantel analogues.T he reported crystal structure of monepantel containsf our crystallographically independent molecules of the S enantiomer,w hich only differ from each other in the ori- entation of the terminal SCF 3 group relative to the rest of the molecule. [5] The central part of the monepantel enantiomer exhibits a Z-type conformation between the chiral carbon atom C* and the carbonyl oxygen atom (on the same sideo ft he central CÀNb ond),t ogether with an E-type conformation between the carbonyl carbona tom and the methylg roup (on opposite sides of the NÀC* bond) along the (O=)CÀN(H)ÀC*À CH 3 moiety.I ndeed, the O-C-N-C*t orsion angles in the independentm olecules are close to 08 (Z-type),b etween 1.9(5) and 5.7(5)8.T his very narrow range was expected because of the pronounced double-bondc haracter of the central bond, due to electron delocalization with the carbonyl group (as revealed by relatively short CÀNb ond lengthsi nt he range 1.355(4)-66 (5) ). Despite the single-bond character of the NÀC* bond (1.452(6)-62(5) ), the C-N-C*-C torsion anglesa lso lie in an arrow range close to 1808 (E-type;165.4(4)-169.0(4)8).
The Z-type conformation is observed in all our new aminoacetonitrile derivatives. The largest O-C-N-C* torsion angle was found in the crystal structure of 3a with av alue as small as 8.6(2)8.M ore interestingly,t he E-type conformation is also generally observedi no ur compounds:a ll C-N-C*-C torsion angles lie in the range 160.4(3)-179.0(1)8,e xcept for 3a with 72.9(2), 62.0(2)8 and 5k with 59(2)/68.0(6)8 (two-component disorder). The crystal structures of 5c, 5d, 5f, 5g,a nd 5k confirmed coordination of the organic species on af errocenyl moiety to form ac arboxyl group. The CO 2 fragment is essentially coplanar with the five-membered ring, and the CÀCb ond between the ring and the carboxyl group lies in the normalr ange for aC (sp 2 )ÀC(sp 2 )s ingle bond (from 1.459(2) for 5k to 1.484(6) for 5f). The relative orientation of the rest of the molecule with the ferrocenyl moiety mainly depends on the intermolecular interactions that link the molecules in the solid state, mainly CÀH···O, CÀH···N, and NÀH···Oh ydrogen bonds, as observed in the crystal structures of the organicm olecules 3a, 3b, 3f,a nd 3g.A ll compounds except 3g crystallized in triclinic,m onoclinic, or orthorhombic centrosymmetric space groups,w hich indicates the presence of both R and S enantiomers (racemates)i nt he crystals. Compound 3g crystallized in ar acemic crystal structure as well, but in the noncentrosymmetric space group Pna2 1 ,w ith two crystallographically independent S and R enantiomer molecules in the asymmetric unit in a1:1 ratio.
Activityagainst H. contortus and Trichostrongylus colubriformis
H. contortus and T. colubriformis are common parasitic nematodes of ruminants and are responsible form ajor economic losses on farms worldwide.
[1e] H. contortus is located in the abomasum( stomach) of the host, where it feeds on blood, whereas T. colubriformis affects the anterior small intestine.
[1e]
Since these speciesc an coexisti ns imilarc limatic regions and co-infect animals, it is desirable to have anthelmintics that efficientlyk ill both parasites.
[1e] Here, all organic precursors and organometallic analogues of monepantel were screenedf or their activities against these two parasites in al arval development assay (LDA, see Supporting Information for details), and the results are summarized in Tables 1a nd 2. At the highest concentrationt ested (10 mgmL À1 ), nine of the 27 compoundss howed moderate activities against H. contortus and T. colubriformis,w ith EC 60 values ranging from 1.80 to 9.50 mgmL À1 (3.30-31.20 mm). The potencies of our compounds were lower than that of the parent compound monepantel against H. contortus and T. colubriformis. [5] Most of the organic intermediates 3a-3k were not active. However,t he insertion of the ferrocenyl moiety generallyi ncreased activity,a so bservedf or compounds 5a, 5e, 5h,a nd 5k.S pecifically, 3a,t he organic precursor of 5a,h ad EC 60 values of 9.50 mgmL À1 (31.20 mm)a nd > 10.00 mgmL À1 (> 32.90 mm)a gainst H. contortus and T. colubriformis,r espectively;b yc ontrast, 5a showed EC 60 values of 2.10 mgmL À1 (4.07 mm)a nd 6.30 mgmL À1 (12.20 mm), respectively.W ithin the series of halide-containing organometallic compounds (5b-5e), 5e,w ith an iodo substituent, showeda nE C 60 of 4.5 mgmL À1 (8.30 mm) against H. contortus.H owever,t his compound was inactive (> 10 mgmL À1 / > 18.45 mm)a gainst T. colubriformis; 5e was the only analogue shown to be active against H. contortus but not against T. colubriformis. Chem. Eur.J. 2016, 22,16602 -16612 www.chemeurj.org 0.022 [a] 0.032 [a] 0.07 [a] 2.40 5.25 2.20 4.81
AAD 85
0.01 [a] 0.021 [a] 0.032 [a] 0.07 [a] n.d.i. [b] n
AAD 96 ivermectin 0.001 [a] 0.001 [a] 0.01 [a] 0.001 [a] 1.00-3.00 1.14-3.43 1.00-3.001.14-3.43
[a] EC 100 value. [5] [b] n.d.i. = non-disclosable information. [25] Chem. Eur.J. 2016, 22, [16602] [16603] [16604] [16605] [16606] [16607] [16608] [16609] [16610] [16611] [16612] www.chemeurj.org Exchange of the SCF 3 group in 5a with an OCF 3 group in 5h led to as light decrease in activity against both parasites (EC 60 increased by 43 %f or H. contortus and by 11 %f or T. colubriformis). Oxidizingt he SCF 3 group of 5a to its sulfone in 5k increasedt he activity slightly (EC 60 decrease of 14 %f or H. contortus and 27 %f or T. colubriformis). However, the sulfoxide 5j had no activitya tt he highest concentrationt ested (> 10 mgmL À1 , > 18.79 mm). Overall, the order of potencies for substituents at the benzamide unit of the active analogues of 5a is S(O) 2 CF 3 ! SCF 3 ! OCF 3 > I.
Replacement of the ferrocenyl moiety of 5a with ac ymantrenyl and ruthenocenyl unit in 9a and 9b,r espectively, rendered the compound inactive against H. contortus and T. colubriformis.T he inactivity of 9b,i np articular, suggestst hat 5a may have ap artial metal-coupled mode of action.B ased on previousb iological studies on ferrocenyl andr uthenocenyl derivatives, [11b, 16b, 19a, 26] it seemsr easonable to speculate that the ferrocenem oiety of 5a,b ut not the ruthenocene moiety in 9b,c an causeR OS generation inside the parasite,a nd that this ROS is at least partly responsible for the activity of 5a.I ndeed, we found that ROS generation by 5a is significantly higher than that of 9b,asd escribed below.
Potentiation of ion-channel current
The ferrocenyl compound 5a was more efficacious against H. contortus and T. colubriformis than its organic counterpart 3a. This difference may arise from the ability of the ferrocenyl compound to potentiate the ion channels better than the organic counterpart. Alternatively,t he presence of the hydrophobic ferrocenyl entity in 5a might enhance the accumulation of the compound in the worm's tissues, or impart as econdary function, such as ROS production.T ot est whether better potentiation of ion channel currents contributed to the increased efficacy of 5a,w ec ompared the ability of compounds 3a, 3l, and 5a to potentiate the monepantel target ACR-23o fC. elegans expressed in oocytes of Xenopus laevis.M onepantel acts as ap ositive allosteric modulator,i ncreasing ion channel current when it is co-applied with an agonist. [6a, c, 7] To quantify the potentiation of this channel by our compounds, we co-applied them with the agonistb etaine (300 mm, % EC 10 )a nd compared the current with control recordings for betaine alone.
All three compounds showed decent efficaciesi nt his assay. The least potent and efficacious compound was 3l,w ith an EC 50 of 9 mm and maximalp otentiation of ninefold compared with the current induced by betaine alone. The potencya nd efficacy of compounds 3a and 5a were similar; 3a had an EC 50 of 2.1 mm,with maximal potentiation of 30-fold, and 5a had an EC 50 of 1.2 mm,w ith maximal potentiationo f3 2-fold (Figure 3) . The less than twofold difference in EC 50 values between these two compounds is negligible, and seems to result mostly from ac onsiderable difference in the slope of the response curves (Hill coefficient:2 .1 for 3a and 11.5 for 5a). The steep slope of the curve for 5a could be caused by limiteda queous solubility affecting the measurements at higherconcentrations.
The efficacyo ft hese three compounds potentiating ACR-23 channels follows the order 5a% 3a> 3l.T his efficacy differs from that against H. contortus and T. colubriformis,w hich follows the order 5a% 3l> 3a.T he marked efficacy of 3a when assayed on the ion channel demonstrates that the ferrocenyl group of 5a and the corresponding aryloxy group of monepantel are not essential for receptor potentiation. Therefore, the aryloxy group of monepanteli sl ikely to contribute to favorable pharmacokinetic properties or pharmacological potency,r ather than efficacy.T he ferrocenyl group of 5a either partially recapitulates these properties, or confers novel toxic properties. These results are consistent with the differences in antiparasitic activity of compounds 5a and 9b,a nd indicate that redox-mediated toxic properties of ferrocenem ay contribute to the toxicityo f5a. 0.022 [a] 0.032 [a] 0.07 [a] 2.40 5.25 2.20 4.81
AAD 85
AAD 96 ivermectin 0.001 [a] 0.001 [a] 0.01 [a] 0.01 [a] 1.00-3.00 1.14-3.43 1.00-3.001.14-3.43
[a] EC 100 value. [5] [b] n.d.i. = non-disclosable information. [25] Chem. Eur.J. 2016, 22,16602 -16612 www.chemeurj.org
Production of ROS
The rationale behind the design of our organometallic-containing monepantel derivatives was the introductiono fm etal-specific modes of action into the organic drug. For example, we envisagedt hat the redox properties of the ferrocene/ferrocenium system in 5a might lead to the production of toxic ROS and thus improve antiparasitica ctivity of the organic drug. [27] As discussed earlier, 5a exhibited moderate activity against H. contortus and T. colubriformis,b ut ruthenocenyl analogue 9b is inactive. To confirm that our compounds have the predicted redox properties,w ea ssessed ROS induced by selected compounds (3a, 5a, 9a,a nd 9b)i nl ivingc ells. Although it would have been ideal to investigate ROS production in parasites,f or practical and technical reasons, we used am ammalian cervical cancer cell line (HeLa). To this end, cells weret reated with different compounds (25 mm for 20 h), and the intracellular ROS was quantified with the oxidation-sensitive fluorescent indicator 2',7'-dichlorofluorescein diacetate (H2DCFDA); tert-butyl hydroperoxide (TBH) was employed as ap ositive control (100 mm for 6h). The ROS level in cells treated with 3a was similar to that of the untreated control cells. By contrast, compound 5a, which results from the attachment of af errocenyl moiety to 3a,p roduced a2 .4-fold higherl evel of ROS than organic precursor 3a alone. ROS inducedb yt he ruthenocenea nalogue 9b wass ignificantly (P < 0.001) lower than for 5a.T hisd ifference in ROS productionm ight be one of the factors responsible for the differencei np otency between 5a and 9b against H. contortus and T. colubriformis ( Figure 4) . Additionally,w e evaluated ROS production followinge xposure to the cymantrene analogue 9a.The ROS level induced by 9a was comparable to its organic precursor (3a).
Activityagainst filarial nematodes
As organometallic derivatization was shown previously to modulate the activity profiles of organic drugs, [11b, 16b, 26] we assayed the activity of our new class of anthelmintics against other parasites.W ew ere eager to assess the activity of our compounds on taxonomically and biologically disparate groups of parasites,i ncluding D. immitis (canine heartworm), Ctenocephalides felis (cat flea), Lucilia cuprina (blow fly), and Rhipicephalus sanguineus (brown dog tick). NeitherA AD 85 nor the compounds synthesized in this study had activity (at the highest concentration tested) on C. felis (100 mgmL )( Supporting Information, Ta ble S4). Compound 5a and four other compounds effective against H. contortus and T. colubriformis in an LDA (3h, 3n, 5h,a nd 5k)e xhibited no activity against D. immitis in am otility assay.H owever,1 2 out of 27 compounds showedc onsiderable activitya gainst D. immitis microfilariae, in as imilarr ange to that of the standard anti-heartworm agent ivermectin. [28] The organicp recursor 3a was extremelya ctive against this parasite, with an EC 50 value of 0.49 mgmL À1 (1.61 mm)a fter 48 h. Other organic precursors (3c, 3j, 3l,a nd 3m)h ad lower activities, with EC 50 valueso f 6.60 mgmL À1 (12.98-27.65 mm). The activities of organometallic derivatives were moderate; 5b, 5c, 5d, 5e, 5g,a nd 7a showed EC 50 values of 2.00-6.60 mgmL À1 (5.10-15.20 mm) . Interestingly, the organometallic analogue 7a,b earing only the benzamide unit and lacking the C 2 spacer,w as the only com- pound that was active against all three parasitic nematodes tested (i.e., H. contortus, T. colubriformis,a nd D. immitis); 7a is also the only compound that displayed activity after only 24 h. The replacement of ferrocenei n5a with ac ymantrene unit makes the resultant analogue 9a active against D. immitis, with an EC 50 value of 1.80 mgmL À1 (3.37 mm). Because AAD activity against filarial nematodes hasn ot been reported previously,w ed ecided to also test ac lose analogue of monepantel, namely,A AD 85. This compound has activity similar to that of 7a;i ti sl essp otent than 3a,b ut acts within 24 h. The D. immitis genome does not appear to encodeaclose homologueo ft he receptors targeted by monepantel, which suggests that this species has an ovel AAD target. Moreover, the lack of ac orrelation between ROS productiona nd activity against D. immitis indicates that the activity against D. immitis is not specifically caused by ROS.
Cytotoxicity and stability of 3a and 9a
An ideal antiparasitic compound would be selective in killing worms while being nontoxic to the mammalian host. We evaluated the selectivity of the two most active compounds against D. immitis, 3a and 9a.W ed etermined their cytotoxicity using noncanceroush uman embryonic kidney( HEK293) cells. The metal-based anticancer drug cisplatin was used as positivec ontrol.C isplatin inhibits the growth of HEK293 cells with an IC 50 value of 39.62 AE 2.61 mm.E ncouragingly,b otho f the compounds 3a and 9a were nontoxic up to 100 mm (the highestc oncentration assayed), and this demonstrates selectivity of the compounds towards parasites.
Another important parameter is the stability of the drug candidates. The stabilities of 3a and 9a were evaluated by 1 HNMR spectroscopy.T he compounds were dissolved in [D 6 ]DMSO/D 2 O[ 1/4 (3a), 2/3 (9a), v/v] and the solutionsk ept in the dark at room temperature. 1 HNMR spectra were recorded at different time intervals. No decomposition of the compounds was observed after a4 8h incubation time, and this confirmst he stability of 3a and 9a in aqueousm edia (see Figure S4 and S5 of the SupportingI nformation).
Conclusion
Given the emergenceofdrug resistance in somesocioeconomically important parasitic nematodes, new strategies are neededt od iscover drugs with novel modes of action. In this study,w ee xplored metal-based variants to expand the chemical space for antiparasiticd rug candidates. Starting from the organic drug monepantel as al ead structure, we designed and synthesized as eries of organic and organometallic analogues by employing two differents trategies. The efficacies of the structurally diverseo rganometallic analogues as well as various organic intermediates were evaluated against H. contortus and T. colubriformis.C ompounds 3a, 3h, 3l, 3n, 5a, 5e, 5h, 5k, and 7a showedm oderate activity against these two nematodes. Further biological assessments on other parasites revealed that 12 of our new compounds had activity against D. immitis microfilariae in the low mgmL À1 range of activity for three compounds ( 3a, 7a and 9a) . Amongt hese three most active compounds, 7a is au nique candidate showing activity against all three parasitic nematodes. The SAR of compounds active against H. contortus and T. colubriformis was distinct from the SAR of compounds active against D. immitis. This suggests au nique mechanism of action for the compounds in the canine heartworm.
Experimental Section
Synthesis and characterization of organic precursors (3a-3 g, 3j-3n)a nd organometallic analogues (5a-5 k, 7a, 7b, 9a, 9b)c an be found in the Supporting Information.
